2024 Testimonies & Briefings
Health Care Price Transparency: Opportunities to Lower Costs and Improve Competition: Addendum
Document submitted September 13, 2024, as an addendum to testimony before the United States Senate Special Committee on Aging on hospital costs and transparency within the commercial market on July 11, 2024 (see below) - July 2024
Health Care Price Transparency: Opportunities to Lower Costs and Improve Competition
Testimony by Chris Whaley, PhD on hospital costs and transparency within the commercial market before the United States Senate Special Committee on Aging - July 2024
Hearing on Strengthening U.S. Economic Leadership: The Role of Competition in Enhancing Economic Resiliency: Addendum
Document submitted June 27, 2024 as an addendum to testimony before the Senate Judiciary Committee, Subcommittee on Competition Policy, Antitrust, and Consumer Protection on June 5, 2024 (see below) - June 2024
Strengthening U.S. Economic Leadership: The Role of Competition in Enhancing Economic Resiliency
Testimony by Erin C. Fuse Brown, JD, MPH on health care consolidation before the Senate Judiciary Committee, Subcommittee on Competition Policy, Antitrust, and Consumer Rights - June 2024
Watch the testimony highlights
Price Transparency and Uses of All-Payer Claims Data
Testimony by Chris Whaley, PhD on price transparency and APCDs before the Oregon State Legislature's Senate Committee on Health Care - May 2024
The Collapse of Private Practice: Examining the Challenges Facing Independent Medicine
Testimony by Ashish K. Jha, MD, MPH to the House Committee on Ways and Means, Subcommittee on Health - May 2024
Read the press release here Watch the testimony highlights
Private Equity Investment in Physician Practices: Legal and Policy Responses
Remarks by Erin C. Fuse Brown, JD, MPH & Presented at “Private Capital, Public Impact: An FTC Workshop on Private Equity in Health Care” - March 2024